Skip to content

OptimizeRx OPRX Payments to Acquire Property, Plant, and Equipment

Payments to Acquire Property, Plant, and Equipment at other companies

Claritev Corporation logo
Claritev CorporationCTEV

Other financials

Income statement

See full
Revenue$19.8M-9.5%
Gross profit$14.9M+11.9%
Operating income$396.0K+119%
Net income-$495.0K+77.5%
EPS (diluted)-$0.03+75.0%

Balance sheet

See full
Cash & equivalents$20.2M+21.7%
Total debt$23.7M-27.7%
Total equity$129.6M+11.5%
Total assets$167.3M-0.3%

Cash flow

See full
Operating cash flow-$467.0K-112%
CapEx$21.0K-22.2%
Free cash flow-$488.0K-113%

Valuation

See full
Market cap$107.34M-54.1%
Enterprise value$110.88M-55.0%
P/E15.7×
P/S-1.2×

Profitability

See full
Gross margin70%+14.1pp
Operating margin13.2%
Net margin6.4%+3.6pp
FCF margin13.4%+4.8pp

Returns & leverage

See full
Return on equity5.6%+3.3pp
Debt / equity0.2×-0.1×
Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's payments to acquire property, plant, and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OptimizeRx's payments to acquire property, plant, and equipment?
OptimizeRx (OPRX) reported payments to acquire property, plant, and equipment of $21K in Q1 2026.
How has OptimizeRx's payments to acquire property, plant, and equipment changed year-over-year?
OptimizeRx's payments to acquire property, plant, and equipment decreased by 22.2% year-over-year, from $27K to $21K.
What is the long-term trend for OptimizeRx's payments to acquire property, plant, and equipment?
Over 4 years (2021 to 2025), OptimizeRx's payments to acquire property, plant, and equipment has grown at a -12.8% compound annual growth rate (CAGR), from $100.32K to $58K.